118 related articles for article (PubMed ID: 12746835)
1. A novel method of generating prostate cancer metastases from orthotopic implants.
Corey E; Quinn JE; Vessella RL
Prostate; 2003 Jul; 56(2):110-4. PubMed ID: 12746835
[TBL] [Abstract][Full Text] [Related]
2. LuCaP 35: a new model of prostate cancer progression to androgen independence.
Corey E; Quinn JE; Buhler KR; Nelson PS; Macoska JA; True LD; Vessella RL
Prostate; 2003 Jun; 55(4):239-46. PubMed ID: 12712403
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
Ellis WJ; Vessella RL; Buhler KR; Bladou F; True LD; Bigler SA; Curtis D; Lange PH
Clin Cancer Res; 1996 Jun; 2(6):1039-48. PubMed ID: 9816265
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.
Corey E; Quinn JE; Bladou F; Brown LG; Roudier MP; Brown JM; Buhler KR; Vessella RL
Prostate; 2002 Jun; 52(1):20-33. PubMed ID: 11992617
[TBL] [Abstract][Full Text] [Related]
5. A Nod Scid mouse model to study human prostate cancer.
Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
[TBL] [Abstract][Full Text] [Related]
6. Intact tissue of gastrointestinal cancer specimen orthotopically transplanted into nude mice.
Cui JH; Krüger U; Vogel I; Lüttges J; Henne-Bruns D; Kremer B; Kalthoff H
Hepatogastroenterology; 1998; 45(24):2087-96. PubMed ID: 9951870
[TBL] [Abstract][Full Text] [Related]
7. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
[TBL] [Abstract][Full Text] [Related]
8. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
McCulloch DR; Opeskin K; Thompson EW; Williams ED
Prostate; 2005 Sep; 65(1):35-43. PubMed ID: 15800936
[TBL] [Abstract][Full Text] [Related]
9. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?
Thalheimer A; Otto C; Bueter M; Illert B; Gattenlohner S; Gasser M; Fein M; Germer CT; Waaga-Gasser AM
Eur Surg Res; 2009; 42(3):195-200. PubMed ID: 19270457
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
Stangelberger A; Schally AV; Nagy A; Szepeshazi K; Kanashiro CA; Halmos G
Prostate; 2006 Feb; 66(2):200-10. PubMed ID: 16173040
[TBL] [Abstract][Full Text] [Related]
12. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
13. [Nude mouse model of human gastric carcinoma metastasis constructed by orthotopic transplantation using organism glue paste technique].
Chen YL; Wei PK; Xu L; Su XM
Ai Zheng; 2005 Feb; 24(2):246-8. PubMed ID: 15694045
[TBL] [Abstract][Full Text] [Related]
14. In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.
Zhang J; Lu Y; Dai J; Yao Z; Kitazawa R; Kitazawa S; Zhao X; Hall DE; Pienta KJ; Keller ET
Prostate; 2004 Jun; 59(4):360-9. PubMed ID: 15065084
[TBL] [Abstract][Full Text] [Related]
15. Use of a SCID mouse model to select for a more aggressive strain of prostate cancer.
Davies MR; Lee YP; Lee C; Zhang X; Afar DE; Lieberman JR
Anticancer Res; 2003; 23(3B):2245-52. PubMed ID: 12894499
[TBL] [Abstract][Full Text] [Related]
16. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
17. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
[TBL] [Abstract][Full Text] [Related]
19. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
20. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
Cruz-Munoz W; Man S; Xu P; Kerbel RS
Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
